{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:25:01Z","timestamp":1787167501370,"version":"build-2736575974"},"reference-count":155,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neural Regen Res"],"published-print":{"date-parts":[[2022]]},"DOI":"10.4103\/1673-5374.332129","type":"journal-article","created":{"date-parts":[[2021,12,10]],"date-time":"2021-12-10T00:51:21Z","timestamp":1639097481000},"page":"1717","source":"Crossref","is-referenced-by-count":14,"title":["Small interfering RNAs based therapies for intracerebral hemorrhage: challenges and progress in drug delivery systems"],"prefix":"10.4103","volume":"17","author":[{"given":"ZahoorA","family":"Shah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"DaniyahA","family":"Almarghalani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SaiH.S.","family":"Boddu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akhila","family":"Kondaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devin","family":"Ta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"RayyanA","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/1673-5374.332129-1","doi-asserted-by":"crossref","unstructured":"Abbott NJ, Patabendige AA, Dolman DE, Yusof SR, Begley DJ (2010) Structure and function of the blood\u2013brain barrier. Neurobiol Dis 37:13-25.","DOI":"10.1016\/j.nbd.2009.07.030"},{"key":"key-10.4103\/1673-5374.332129-2","doi-asserted-by":"crossref","unstructured":"Agarwal S, Simon AR, Goel V, Habtemariam BA, Clausen VA, Kim JB, Robbie GJ (2020) Pharmacokinetics and pharmacodynamics of the small interfering ribonucleic acid, givosiran, in patients with acute hepatic porphyria. Clin Pharmacol Ther 108:63-72.","DOI":"10.1002\/cpt.1802"},{"key":"key-10.4103\/1673-5374.332129-3","doi-asserted-by":"crossref","unstructured":"Akinc A, Maier MA, Manoharan M, Fitzgerald K, Jayaraman M, Barros S, Ansell S, Du X, Hope MJ, Madden TD (2019) The Onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugs. Nat Nanotechnol 14:1084-1087.","DOI":"10.1038\/s41565-019-0591-y"},{"key":"key-10.4103\/1673-5374.332129-4","doi-asserted-by":"crossref","unstructured":"Alameh M, DeJesus D, Jean M, Darras V, Thibault M, Lavertu M, Buschmann MD, Merzouki A (2012) Low molecular weight chitosan nanoparticulate system at low N: P ratio for nontoxic polynucleotide delivery. Int J Nanomedicine 7:1399-1414.","DOI":"10.2147\/IJN.S26571"},{"key":"key-10.4103\/1673-5374.332129-5","doi-asserted-by":"crossref","unstructured":"Alvarez-Erviti L, Seow Y, Yin H, Betts C, Lakhal S, Wood MJ (2011) Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nat Biotechnol 29:341-345.","DOI":"10.1038\/nbt.1807"},{"key":"key-10.4103\/1673-5374.332129-6","doi-asserted-by":"crossref","unstructured":"An SJ, Kim TJ, Yoon BW (2017) Epidemiology, risk factors, and clinical features of intracerebral hemorrhage: an update. J Stroke 19:3-10.","DOI":"10.5853\/jos.2016.00864"},{"key":"key-10.4103\/1673-5374.332129-7","doi-asserted-by":"crossref","unstructured":"Anderson JM, Shive MS (2012) Biodegradation and biocompatibility of PLA and PLGA microspheres. Adv Drug Deliv Rev 64:72-82.","DOI":"10.1016\/j.addr.2012.09.004"},{"key":"key-10.4103\/1673-5374.332129-8","doi-asserted-by":"crossref","unstructured":"Ara\u00fajo RVd, Santos SdS, Igne Ferreira E, Giarolla J (2018) New advances in general biomedical applications of PAMAM dendrimers. Molecules 23:2849.","DOI":"10.3390\/molecules23112849"},{"key":"key-10.4103\/1673-5374.332129-9","doi-asserted-by":"crossref","unstructured":"Ayadi L, Galvanin A, Pichot F, Marchand V, Motorin Y (2019) RNA ribose methylation (2\u2032-O-methylation): Occurrence, biosynthesis and biological functions. Biochim Biophys Acta Gene Regul Mech 1862:253-269.","DOI":"10.1016\/j.bbagrm.2018.11.009"},{"key":"key-10.4103\/1673-5374.332129-10","doi-asserted-by":"crossref","unstructured":"Bachu RD, Chowdhury P, Al-Saedi ZH, Karla PK, Boddu SH (2018) Ocular drug delivery barriers\u2014role of nanocarriers in the treatment of anterior segment ocular diseases. Pharmaceutics 10:28.","DOI":"10.3390\/pharmaceutics10010028"},{"key":"key-10.4103\/1673-5374.332129-11","doi-asserted-by":"crossref","unstructured":"Banks WA (2016) From blood-brain barrier to blood-brain interface: new opportunities for CNS drug delivery. Nat Rev Drug Discov 15:275-292.","DOI":"10.1038\/nrd.2015.21"},{"key":"key-10.4103\/1673-5374.332129-12","doi-asserted-by":"crossref","unstructured":"Borel F, Kay MA, Mueller C (2014) Recombinant AAV as a platform for translating the therapeutic potential of RNA interference. Mol Ther 22:692-701.","DOI":"10.1038\/mt.2013.285"},{"key":"key-10.4103\/1673-5374.332129-13","doi-asserted-by":"crossref","unstructured":"Bozzuto G, Molinari A (2015) Liposomes as nanomedical devices. Int J Nanomedicine 10:975-999.","DOI":"10.2147\/IJN.S68861"},{"key":"key-10.4103\/1673-5374.332129-14","doi-asserted-by":"crossref","unstructured":"Cao Y, Tan YF, Wong YS, Liew MWJ, Venkatraman S (2019) Recent advances in chitosan-based carriers for gene delivery. Mar Drugs 17:381.","DOI":"10.3390\/md17060381"},{"key":"key-10.4103\/1673-5374.332129-15","doi-asserted-by":"crossref","unstructured":"Chen C, Mei H, Shi W, Deng J, Zhang B, Guo T, Wang H, Hu Y (2013) EGFP-EGF1-conjugated PLGA nanoparticles for targeted delivery of siRNA into injured brain microvascular endothelial cells for efficient RNA interference. PLoS One 8:e60860.","DOI":"10.1371\/journal.pone.0060860"},{"key":"key-10.4103\/1673-5374.332129-16","doi-asserted-by":"crossref","unstructured":"Chen S, Peng J, Sherchan P, Ma Y, Xiang S, Yan F, Zhao H, Jiang Y, Wang N, Zhang JH, Zhang H (2020a) TREM2 activation attenuates neuroinflammation and neuronal apoptosis via PI3K\/Akt pathway after intracerebral hemorrhage in mice. J Neuroinflammation 17:168.","DOI":"10.1186\/s12974-020-01853-x"},{"key":"key-10.4103\/1673-5374.332129-17","doi-asserted-by":"crossref","unstructured":"Chen W, Hu Y, Ju D (2020b) Gene therapy for neurodegenerative disorders: advances, insights and prospects. Acta Pharm Sin B 10:1347-1359.","DOI":"10.1016\/j.apsb.2020.01.015"},{"key":"key-10.4103\/1673-5374.332129-18","doi-asserted-by":"crossref","unstructured":"Choudhury SR, Hudry E, Maguire CA, Sena-Esteves M, Breakefield XO, Grandi P (2017) Viral vectors for therapy of neurologic diseases. Neuropharmacology 120:63-80.","DOI":"10.1016\/j.neuropharm.2016.02.013"},{"key":"key-10.4103\/1673-5374.332129-19","doi-asserted-by":"crossref","unstructured":"Chronopoulou L, Massimi M, Giardi MF, Cametti C, Devirgiliis LC, Dentini M, Palocci C (2013) Chitosan-coated PLGA nanoparticles: a sustained drug release strategy for cell cultures. Colloids Surf B Biointerfaces 103:310-317.","DOI":"10.1016\/j.colsurfb.2012.10.063"},{"key":"key-10.4103\/1673-5374.332129-20","doi-asserted-by":"crossref","unstructured":"Conniot J, Talebian S, Sim\u00f5es S, Ferreira L, Conde J (2021) Revisiting gene delivery to the brain: silencing and editing. Biomater Sci 9:1065-1087.","DOI":"10.1039\/D0BM01278E"},{"key":"key-10.4103\/1673-5374.332129-21","doi-asserted-by":"crossref","unstructured":"Daka A, Peer D (2012) RNAi-based nanomedicines for targeted personalized therapy. Adv Drug Deliv Rev 64:1508-1521.","DOI":"10.1016\/j.addr.2012.08.014"},{"key":"key-10.4103\/1673-5374.332129-22","doi-asserted-by":"crossref","unstructured":"Dang L, Dong X, Yang J (2021) Influence of nanoparticle-loaded edaravone on postoperative effects in patients with cerebral hemorrhage. J Nanosci Nanotechnol 21:1202-1211.","DOI":"10.1166\/jnn.2021.18668"},{"key":"key-10.4103\/1673-5374.332129-23","doi-asserted-by":"crossref","unstructured":"Davis ME, Zuckerman JE, Choi CHJ, Seligson D, Tolcher A, Alabi CA, Yen Y, Heidel JD, Ribas A (2010) Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles. Nature 464:1067-1070.","DOI":"10.1038\/nature08956"},{"key":"key-10.4103\/1673-5374.332129-24","doi-asserted-by":"crossref","unstructured":"Dizaj SM, Jafari S, Khosroushahi AY (2014) A sight on the current nanoparticle-based gene delivery vectors. Nanoscale Res Lett 9:252.","DOI":"10.1186\/1556-276X-9-252"},{"key":"key-10.4103\/1673-5374.332129-25","doi-asserted-by":"crossref","unstructured":"Dong Y, Siegwart DJ, Anderson DG (2019) Strategies, design, and chemistry in siRNA delivery systems. Adv Drug Deliv Rev 144:133-147.","DOI":"10.1016\/j.addr.2019.05.004"},{"key":"key-10.4103\/1673-5374.332129-26","doi-asserted-by":"crossref","unstructured":"Dua K, Wadhwa R, Singhvi G, Rapalli V, Shukla SD, Shastri MD, Gupta G, Satija S, Mehta M, Khurana N (2019) The potential of siRNA based drug delivery in respiratory disorders: Recent advances and progress. Drug Dev Res 80:714-730.","DOI":"10.1002\/ddr.21571"},{"key":"key-10.4103\/1673-5374.332129-27","doi-asserted-by":"crossref","unstructured":"Eberling JL, Jagust WJ, Christine CW, Starr P, Larson P, Bankiewicz KS, Aminoff MJ (2008) Results from a phase I safety trial of hAADC gene therapy for Parkinson disease. Neurology 70:1980-1983.","DOI":"10.1212\/01.wnl.0000312381.29287.ff"},{"key":"key-10.4103\/1673-5374.332129-28","doi-asserted-by":"crossref","unstructured":"Fu S, Luo X, Wu X, Zhang T, Gu L, Wang Y, Gao M, Cheng Y, Xie Z (2020) Activation of the melanocortin-1 receptor by NDP-MSH attenuates oxidative stress and neuronal apoptosis through PI3K\/Akt\/Nrf2 pathway after intracerebral hemorrhage in mice. Oxid Med Cell Longev doi:10.1155\/2020\/8864100.","DOI":"10.1155\/2020\/8864100"},{"key":"key-10.4103\/1673-5374.332129-29","doi-asserted-by":"crossref","unstructured":"Fukuta T, Ishii T, Asai T, Sato A, Kikuchi T, Shimizu K, Minamino T, Oku N (2015) Treatment of stroke with liposomal neuroprotective agents under cerebral ischemia conditions. Eur J Pharm Biopharm 97:1-7.","DOI":"10.1016\/j.ejpb.2015.09.020"},{"key":"key-10.4103\/1673-5374.332129-30","doi-asserted-by":"crossref","unstructured":"Gan Y, Jing Z, Stetler RA, Cao G (2013) Gene delivery with viral vectors for cerebrovascular diseases. Front Biosci (Elite Ed) 5:188-203.","DOI":"10.2741\/E607"},{"key":"key-10.4103\/1673-5374.332129-31","doi-asserted-by":"crossref","unstructured":"Gao Y, Wang Z-Y, Zhang J, Zhang Y, Huo H, Wang T, Jiang T, Wang S (2014) RVG-peptide-linked trimethylated chitosan for delivery of siRNA to the brain. Biomacromolecules 15:1010-1018.","DOI":"10.1021\/bm401906p"},{"key":"key-10.4103\/1673-5374.332129-32","doi-asserted-by":"crossref","unstructured":"Gargano G, Oliviero A, Oliva F, Maffulli N (2021) Small interfering RNAs in tendon homeostasis. Br Med Bull doi: 10.1093\/bmb\/ldaa040.","DOI":"10.1093\/bmb\/ldaa040"},{"key":"key-10.4103\/1673-5374.332129-33","unstructured":"Gavrilov K, Saltzman WM (2012) Therapeutic siRNA: principles, challenges, and strategies. Yale J Biol Med 85:187-200."},{"key":"key-10.4103\/1673-5374.332129-34","doi-asserted-by":"crossref","unstructured":"GBD 2016 Lifetime Risk of Stroke Collaborators, Feigin VL, Nguyen G, Cercy K, Johnson CO, Alam T, Parmar PG, Abajobir AA, Abate KH, Abd-Allah F, Abejie AN, Abyu GY, Ademi Z, Agarwal G, Ahmed MB, Akinyemi RO, Al-Raddadi R, Aminde LN, Amlie-Lefond C, Ansari H, et al. (2018) Global, regional, and country-specific lifetime risks of stroke, 1990 and 2016. N Engl J Med 379:2429-2437.","DOI":"10.1056\/NEJMoa1804492"},{"key":"key-10.4103\/1673-5374.332129-35","doi-asserted-by":"crossref","unstructured":"Gomes-da-Silva LgC, Fonseca NA, Moura V, Pedroso de Lima MC, Sim\u00f5es Sr, Moreira JoN (2012) Lipid-based nanoparticles for siRNA delivery in cancer therapy: paradigms and challenges. Acc Chem Res 45:1163-1171.","DOI":"10.1021\/ar300048p"},{"key":"key-10.4103\/1673-5374.332129-36","doi-asserted-by":"crossref","unstructured":"Gomes MJ, Fernandes C, Martins S, Borges F, Sarmento B (2017) Tailoring lipid and polymeric nanoparticles as siRNA carriers towards the blood-brain barrier \u2013 from targeting to safe administration. J Neuroimmune Pharmacol 12:107-119.","DOI":"10.1007\/s11481-016-9685-6"},{"key":"key-10.4103\/1673-5374.332129-37","doi-asserted-by":"crossref","unstructured":"Gosselet F, Loiola RA, Roig A, Rosell A, Culot M (2021) Central nervous system delivery of molecules across the blood-brain barrier. Neurochem Int 144:104952.","DOI":"10.1016\/j.neuint.2020.104952"},{"key":"key-10.4103\/1673-5374.332129-38","doi-asserted-by":"crossref","unstructured":"Gray SJ, Matagne V, Bachaboina L, Yadav S, Ojeda SR, Samulski RJ (2011) Preclinical differences of intravascular AAV9 delivery to neurons and glia: a comparative study of adult mice and nonhuman primates. Mol Ther 19:1058-1069.","DOI":"10.1038\/mt.2011.72"},{"key":"key-10.4103\/1673-5374.332129-39","doi-asserted-by":"crossref","unstructured":"Guo T, Guo Y, Gong Y, Ji J, Hao S, Deng J, Wang B (2019) An enhanced charge-driven intranasal delivery of nicardipine attenuates brain injury after intracerebral hemorrhage. Int J Pharm 566:46-56.","DOI":"10.1016\/j.ijpharm.2019.05.050"},{"key":"key-10.4103\/1673-5374.332129-40","doi-asserted-by":"crossref","unstructured":"Hajj KA, Whitehead KA (2017) Tools for translation: non-viral materials for therapeutic mRNA delivery. Nat Rev Mater 2:1-17.","DOI":"10.1038\/natrevmats.2017.56"},{"key":"key-10.4103\/1673-5374.332129-41","doi-asserted-by":"crossref","unstructured":"Hardee CL, Ar\u00e9valo-Soliz LM, Hornstein BD, Zechiedrich L (2017) Advances in non-viral DNA vectors for gene therapy. Genes 8:65.","DOI":"10.3390\/genes8020065"},{"key":"key-10.4103\/1673-5374.332129-42","doi-asserted-by":"crossref","unstructured":"Hassanpour S, Kim HJ, Saadati A, Tebon P, Xue C, van den Dolder FW, Thakor J, Baradaran B, Mosafer J, Baghbanzadeh A, de Barros NR, Hashemzaei M, Lee KJ, Lee J, Zhang S, Sun W, Cho HJ, Ahadian S, Ashammakhi N, Dokmeci MR, et al. (2020) Thrombolytic agents: nanocarriers in controlled release. Small 16:e2001647.","DOI":"10.1002\/smll.202001647"},{"key":"key-10.4103\/1673-5374.332129-43","doi-asserted-by":"crossref","unstructured":"Hocquemiller M, Giersch L, Audrain M, Parker S, Cartier N (2016) Adeno-associated virus-based gene therapy for CNS diseases. Hum Gene Ther 27:478-496.","DOI":"10.1089\/hum.2016.087"},{"key":"key-10.4103\/1673-5374.332129-44","doi-asserted-by":"crossref","unstructured":"Hou Y, Hu Z, Gong X, Yang B (2020) HSPB8 overexpression prevents disruption of blood-brain barrier after intracerebral hemorrhage in rats through Akt\/GSK3\u03b2\/\u03b2-catenin signaling pathway. Aging 12:17568-17581.","DOI":"10.18632\/aging.103773"},{"key":"key-10.4103\/1673-5374.332129-45","doi-asserted-by":"crossref","unstructured":"Hu Q, Chen C, Khatibi NH, Li L, Yang L, Wang K, Han J, Duan W, Zhang JH, Zhou C (2011) Lentivirus-mediated transfer of MMP-9 shRNA provides neuroprotection following focal ischemic brain injury in rats. Brain Res 1367:347-359.","DOI":"10.1016\/j.brainres.2010.10.002"},{"key":"key-10.4103\/1673-5374.332129-46","doi-asserted-by":"crossref","unstructured":"Huang BR, Chang PC, Yeh WL, Lee CH, Tsai CF, Lin C, Lin HY, Liu YS, Wu CYJ, Ko PY (2014) Anti-neuroinflammatory effects of the calcium channel blocker nicardipine on microglial cells: implications for neuroprotection. PLoS One 9:e91167.","DOI":"10.1371\/journal.pone.0091167"},{"key":"key-10.4103\/1673-5374.332129-47","unstructured":"Huang YY (2019) Approval of the first-ever RNAi therapeutics and its technological development history. Prog Biochem Biophys 46:313-322."},{"key":"key-10.4103\/1673-5374.332129-48","doi-asserted-by":"crossref","unstructured":"Hutson TH, Foster E, Moon LD, Y\u00e1nez-Munoz RJ (2014) Lentiviral vector-mediated RNA silencing in the central nervous system. Hum Gene Ther Methods 25:14-32.","DOI":"10.1089\/hgtb.2013.016"},{"key":"key-10.4103\/1673-5374.332129-49","doi-asserted-by":"crossref","unstructured":"Ifediba MA, Medarova Z, Ng SW, Yang J, Moore A (2010) siRNA delivery to CNS cells using a membrane translocation peptide. Bioconjug Chem 21:803-806.","DOI":"10.1021\/bc900488e"},{"key":"key-10.4103\/1673-5374.332129-50","doi-asserted-by":"crossref","unstructured":"Jeong WJ, Bu J, Kubiatowicz LJ, Chen SS, Kim Y, Hong S (2018) Peptide\u2013nanoparticle conjugates: a next generation of diagnostic and therapeutic platforms? Nano Converg 5:38.","DOI":"10.1186\/s40580-018-0170-1"},{"key":"key-10.4103\/1673-5374.332129-51","doi-asserted-by":"crossref","unstructured":"Jin J, Zhou F, Zhu J, Zeng W, Liu Y (2020) MiR-26a inhibits the inflammatory response of microglia by targeting HMGA2 in intracerebral hemorrhage. J Int Med Res doi:10.1177\/0300060520929615.","DOI":"10.1177\/0300060520929615"},{"key":"key-10.4103\/1673-5374.332129-52","doi-asserted-by":"crossref","unstructured":"Jin J, Bae KH, Yang H, Lee SJ, Kim H, Kim Y, Joo KM, Seo SW, Park TG, Nam D-H (2011) In vivo specific delivery of c-Met siRNA to glioblastoma using cationic solid lipid nanoparticles. Bioconjug Chem 22:2568-2572.","DOI":"10.1021\/bc200406n"},{"key":"key-10.4103\/1673-5374.332129-53","doi-asserted-by":"crossref","unstructured":"Kim ID, Shin JH, Kim SW, Choi S, Ahn J, Han PL, Park JS, Lee JK (2012) Intranasal delivery of HMGB1 siRNA confers target gene knockdown and robust neuroprotection in the postischemic brain. Mol Ther 20:829-839.","DOI":"10.1038\/mt.2011.291"},{"key":"key-10.4103\/1673-5374.332129-54","doi-asserted-by":"crossref","unstructured":"Kim JY, Han Y, Lee JE, Yenari MA (2018) The 70-kDa heat shock protein (Hsp70) as a therapeutic target for stroke. Expert Opin Ther Targets 22:191-199.","DOI":"10.1080\/14728222.2018.1439477"},{"key":"key-10.4103\/1673-5374.332129-55","doi-asserted-by":"crossref","unstructured":"Kuang Y, An S, Guo Y, Huang S, Shao K, Liu Y, Li J, Ma H, Jiang C (2013) T7 peptide-functionalized nanoparticles utilizing RNA interference for glioma dual targeting. Int J Pharm 454:11-20.","DOI":"10.1016\/j.ijpharm.2013.07.019"},{"key":"key-10.4103\/1673-5374.332129-56","doi-asserted-by":"crossref","unstructured":"Kwon EJ, Skalak M, Lo Bu R, Bhatia SN (2016) Neuron-targeted nanoparticle for siRNA delivery to traumatic brain injuries. ACS Nano 10:7926-7933.","DOI":"10.1021\/acsnano.6b03858"},{"key":"key-10.4103\/1673-5374.332129-57","doi-asserted-by":"crossref","unstructured":"Leclerc JL, Blackburn S, Neal D, Mendez NV, Wharton JA, Waters MF, Dor\u00e9 S (2015) Haptoglobin phenotype predicts the development of focal and global cerebral vasospasm and may influence outcomes after aneurysmal subarachnoid hemorrhage. Proc Natl Acad Sci U S A 112:1155-1160.","DOI":"10.1073\/pnas.1412833112"},{"key":"key-10.4103\/1673-5374.332129-58","doi-asserted-by":"crossref","unstructured":"Leclerc JL, Santiago-Moreno J, Dang A, Lampert AS, Cruz PE, Rosario AM, Golde TE, Dor\u00e9 S (2018) Increased brain hemopexin levels improve outcomes after intracerebral hemorrhage. J Cereb Blood Flow Metab 38:1032-1046.","DOI":"10.1177\/0271678X16679170"},{"key":"key-10.4103\/1673-5374.332129-59","doi-asserted-by":"crossref","unstructured":"Lee JM, Yoon TJ, Cho YS (2013) Recent developments in nanoparticle-based siRNA delivery for cancer therapy. Biomed Res Int doi:10.1155\/2013\/782041.","DOI":"10.1155\/2013\/782041"},{"key":"key-10.4103\/1673-5374.332129-60","doi-asserted-by":"crossref","unstructured":"LeWitt PA, Rezai AR, Leehey MA, Ojemann SG, Flaherty AW, Eskandar EN, Kostyk SK, Thomas K, Sarkar A, Siddiqui MS (2011) AAV2-GAD gene therapy for advanced Parkinson\u2019s disease: a double-blind, sham-surgery controlled, randomised trial. Lancet Neurol 10:309-319.","DOI":"10.1016\/S1474-4422(11)70039-4"},{"key":"key-10.4103\/1673-5374.332129-61","doi-asserted-by":"crossref","unstructured":"Li F, Yang B, Li T, Gong X, Zhou F, Hu Z (2019) HSPB8 over-expression prevents disruption of blood-brain barrier by promoting autophagic flux after cerebral ischemia\/reperfusion injury. J Neurochem 148:97-113.","DOI":"10.1111\/jnc.14626"},{"key":"key-10.4103\/1673-5374.332129-62","doi-asserted-by":"crossref","unstructured":"Li W, Wang Y (2017) Angiogenesis and Neurogenesis after ischemic stroke. In: Translational research in stroke (, ed), pp297-317. Berlin:Springer.","DOI":"10.1007\/978-981-10-5804-2_14"},{"key":"key-10.4103\/1673-5374.332129-63","doi-asserted-by":"crossref","unstructured":"Li Z, Tan S, Li S, Shen Q, Wang K (2017) Cancer drug delivery in the nano era: an overview and perspectives (Review). Oncol Rep 38:611-624.","DOI":"10.3892\/or.2017.5718"},{"key":"key-10.4103\/1673-5374.332129-64","doi-asserted-by":"crossref","unstructured":"Liu C, Zhang N (2011) Nanoparticles in gene therapy: principles, prospects, and challenges. In: Progress in molecular biology and translational science (Lapchak PA, Yang GY, eds), pp509-562. Amsterdam:Elsevier.","DOI":"10.1016\/B978-0-12-416020-0.00013-9"},{"key":"key-10.4103\/1673-5374.332129-65","doi-asserted-by":"crossref","unstructured":"Liu D, Mao P, Huang Y, Liu Y, Liu X, Pang X, Li Y (2014) Proteomic analysis of lung tissue in a rat acute lung injury model: identification of PRDX1 as a promoter of inflammation. Mediators Inflamm doi:10.1155\/2014\/469358.","DOI":"10.1155\/2014\/469358"},{"key":"key-10.4103\/1673-5374.332129-66","doi-asserted-by":"crossref","unstructured":"Lu Y, Zhang XS, Zhou XM, Gao YY, Chen CL, Liu JP, Ye ZN, Zhang ZH, Wu LY, Li W (2019) Peroxiredoxin 1\/2 protects brain against H2O2-induced apoptosis after subarachnoid hemorrhage. FASEB J 33:3051-3062.","DOI":"10.1096\/fj.201801150R"},{"key":"key-10.4103\/1673-5374.332129-67","doi-asserted-by":"crossref","unstructured":"Malhotra M, Tomaro-Duchesneau C, Saha S, Prakash S (2013) Intranasal, siRNA delivery to the brain by TAT\/MGF tagged PEGylated chitosan nanoparticles. J Pharm (Cairo) doi:10.1155\/2013\/812387.","DOI":"10.1155\/2013\/812387"},{"key":"key-10.4103\/1673-5374.332129-68","doi-asserted-by":"crossref","unstructured":"Mann AP, Scodeller P, Hussain S, Joo J, Kwon E, Braun GB, Molder T, She ZG, Kotamraju VR, Ranscht B, Krajewski S, Teesalu T, Bhatia S, Sailor MJ, Ruoslahti E (2016) A peptide for targeted, systemic delivery of imaging and therapeutic compounds into acute brain injuries. Nat Commun 7:11980.","DOI":"10.1038\/ncomms11980"},{"key":"key-10.4103\/1673-5374.332129-69","doi-asserted-by":"crossref","unstructured":"Manservigi R, Argnani R, Marconi P (2010) HSV recombinant vectors for gene therapy. Open Virol J 4:123-156.","DOI":"10.2174\/1874357901004010123"},{"key":"key-10.4103\/1673-5374.332129-70","doi-asserted-by":"crossref","unstructured":"Manzari MT, Shamay Y, Kiguchi H, Rosen N, Scaltriti M, Heller DA (2021) Targeted drug delivery strategies for precision medicines. Nat Rev Mater 6:351-370.","DOI":"10.1038\/s41578-020-00269-6"},{"key":"key-10.4103\/1673-5374.332129-71","doi-asserted-by":"crossref","unstructured":"Mao L, Li P, Zhu W, Cai W, Liu Z, Wang Y, Luo W, Stetler RA, Leak RK, Yu W, Gao Y, Chen J, Chen G, Hu X (2017) Regulatory T cells ameliorate tissue plasminogen activator-induced brain haemorrhage after stroke. Brain 140:1914-1931.","DOI":"10.1093\/brain\/awx111"},{"key":"key-10.4103\/1673-5374.332129-72","doi-asserted-by":"crossref","unstructured":"Marques M, Cordeiro M, Marinho M, Vian C, Vaz G, Alves B, Jardim R, Hort M, Dora C, Horn A (2020) Curcumin-loaded nanoemulsion improves haemorrhagic stroke recovery in wistar rats. Brain Res 1746:147007.","DOI":"10.1016\/j.brainres.2020.147007"},{"key":"key-10.4103\/1673-5374.332129-73","doi-asserted-by":"crossref","unstructured":"Marquez AR, Madu CO, Lu Y (2018) An overview of various carriers for siRNA delivery. Oncomedicine 3:48-58.","DOI":"10.7150\/oncm.25785"},{"key":"key-10.4103\/1673-5374.332129-74","doi-asserted-by":"crossref","unstructured":"Marqus S, Pirogova E, Piva TJ (2017) Evaluation of the use of therapeutic peptides for cancer treatment. J Biomed Sci 24:21.","DOI":"10.1186\/s12929-017-0328-x"},{"key":"key-10.4103\/1673-5374.332129-75","unstructured":"Martinez-Veracoechea F, Frenkel D (2012) Designing super-selectivity in multivalent nano-particle binding. APS 2012:X39.002."},{"key":"key-10.4103\/1673-5374.332129-76","doi-asserted-by":"crossref","unstructured":"Mendon\u00e7a MCP, Radaic A, Garcia-Fossa F, da Cruz-H\u00f6fling MA, Vinolo MAR, de Jesus MB (2020) The in vivo toxicological profile of cationic solid lipid nanoparticles. Drug Deliv Transl Res 10:34-42.","DOI":"10.1007\/s13346-019-00657-8"},{"key":"key-10.4103\/1673-5374.332129-77","doi-asserted-by":"crossref","unstructured":"Merkel SF, Andrews AM, Lutton EM, Mu D, Hudry E, Hyman BT, Maguire CA, Ramirez SH (2017) Trafficking of adeno-associated virus vectors across a model of the blood\u2013brain barrier; a comparative study of transcytosis and transduction using primary human brain endothelial cells. J Neurochem 140:216-230.","DOI":"10.1111\/jnc.13861"},{"key":"key-10.4103\/1673-5374.332129-78","doi-asserted-by":"crossref","unstructured":"Monty MA, Islam MA, Nan X, Tan J, Tuhin IJ, Tang X, Miao M, Wu D, Yu L (2021) Emerging role of RNA interference in immune cells engineering and its therapeutic synergism in immunotherapy. Br J Pharmacol 178:1741-1755.","DOI":"10.1111\/bph.15414"},{"key":"key-10.4103\/1673-5374.332129-79","doi-asserted-by":"crossref","unstructured":"Naso MF, Tomkowicz B, Perry WL, 3rd, Strohl WR (2017) Adeno-Associated Virus (AAV) as a vector for gene therapy. BioDrugs 31:317-334.","DOI":"10.1007\/s40259-017-0234-5"},{"key":"key-10.4103\/1673-5374.332129-80","doi-asserted-by":"crossref","unstructured":"Natesan S, Boddu SH, Krishnaswami V, Shahwan M (2020) The role of nano-ophthalmology in treating dry eye disease. Pharm Nanotechnol 8:258-289.","DOI":"10.2174\/2211738508666200628034227"},{"key":"key-10.4103\/1673-5374.332129-81","doi-asserted-by":"crossref","unstructured":"Nayerossadat N, Maedeh T, Ali PA (2012) Viral and nonviral delivery systems for gene delivery. Adv Biomed Res 1:27.","DOI":"10.4103\/2277-9175.98152"},{"key":"key-10.4103\/1673-5374.332129-82","doi-asserted-by":"crossref","unstructured":"Neuberg P, Kichler A (2014) Recent developments in nucleic acid delivery with polyethylenimines. In: Advances in genetics (Kumar D, ed), pp263-288. Amsterdam:Elsevier.","DOI":"10.1016\/B978-0-12-800148-6.00009-2"},{"key":"key-10.4103\/1673-5374.332129-83","doi-asserted-by":"crossref","unstructured":"Neve RL (2012) Overview of gene delivery into cells using HSV-1-based vectors. Curr Protoc Neurosci doi: 10.1002\/0471142301.ns0412s61..","DOI":"10.1002\/0471142301.ns0412s61"},{"key":"key-10.4103\/1673-5374.332129-84","doi-asserted-by":"crossref","unstructured":"Nidetz NF, McGee MC, Tse LV, Li C, Cong L, Li Y, Huang W (2020) Adeno-associated viral vector-mediated immune responses: Understanding barriers to gene delivery. Pharmacol Ther 207:107453.","DOI":"10.1016\/j.pharmthera.2019.107453"},{"key":"key-10.4103\/1673-5374.332129-85","doi-asserted-by":"crossref","unstructured":"Nitta SK, Numata K (2013) Biopolymer-based nanoparticles for drug\/gene delivery and tissue engineering. Int J Mol Sci 14:1629-1654.","DOI":"10.3390\/ijms14011629"},{"key":"key-10.4103\/1673-5374.332129-86","doi-asserted-by":"crossref","unstructured":"Oller-Salvia B, Teixid\u00f3 M, Giralt E (2013) From venoms to BBB shuttles: synthesis and blood\u2013brain barrier transport assessment of apamin and a nontoxic analog. Biopolymers 100:675-686.","DOI":"10.1002\/bip.22257"},{"key":"key-10.4103\/1673-5374.332129-87","doi-asserted-by":"crossref","unstructured":"Ozpolat B, Sood AK, Lopez-Berestein G (2014) Liposomal siRNA nanocarriers for cancer therapy. Adv Drug Deliv Rev 66:110-116.","DOI":"10.1016\/j.addr.2013.12.008"},{"key":"key-10.4103\/1673-5374.332129-88","doi-asserted-by":"crossref","unstructured":"Pandit J, Sultana Y, Aqil M (2017) Chitosan-coated PLGA nanoparticles of bevacizumab as novel drug delivery to target retina: optimization, characterization, and in vitro toxicity evaluation. Artif Cells Nanomed Biotechnol 45:1397-1407.","DOI":"10.1080\/21691401.2016.1243545"},{"key":"key-10.4103\/1673-5374.332129-89","doi-asserted-by":"crossref","unstructured":"Patil S, Gao YG, Lin X, Li Y, Dang K, Tian Y, Zhang WJ, Jiang SF, Qadir A, Qian AR (2019) The development of functional non-viral vectors for gene delivery. Int J Mol Sci 20:5491.","DOI":"10.3390\/ijms20215491"},{"key":"key-10.4103\/1673-5374.332129-90","doi-asserted-by":"crossref","unstructured":"Peng T, Britton GL, Kim H, Cattano D, Aronowski J, Grotta J, McPherson DD, Huang SL (2013) Therapeutic time window and dose dependence of xenon delivered via echogenic liposomes for neuroprotection in stroke. CNS Neurosci Ther 19:773-784.","DOI":"10.1111\/cns.12159"},{"key":"key-10.4103\/1673-5374.332129-91","doi-asserted-by":"crossref","unstructured":"Piguet F, de Saint Denis T, Audouard E, Beccaria K, Andr\u00e9 A, Wurtz G, Schatz R, Alves S, Sevin C, Zerah M (2021) The challenge of gene therapy for neurological diseases: strategies and tools to achieve efficient delivery to the central nervous system. Hum Gene Ther 32:349-374.","DOI":"10.1089\/hum.2020.105"},{"key":"key-10.4103\/1673-5374.332129-92","doi-asserted-by":"crossref","unstructured":"Prchal JT (2017) Ironing out the role of hepcidin in infection. Blood 130:233-234.","DOI":"10.1182\/blood-2017-05-783688"},{"key":"key-10.4103\/1673-5374.332129-93","doi-asserted-by":"crossref","unstructured":"Raftery R, O\u2019brien FJ, Cryan SA (2013) Chitosan for gene delivery and orthopedic tissue engineering applications. Molecules 18:5611-5647.","DOI":"10.3390\/molecules18055611"},{"key":"key-10.4103\/1673-5374.332129-94","unstructured":"Rajashekar D, Liang JW (2021) Intracerebral Hemorrhage. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK553103\/."},{"key":"key-10.4103\/1673-5374.332129-95","doi-asserted-by":"crossref","unstructured":"Ramachandran PS, Keiser MS, Davidson BL (2013) Recent advances in RNA interference therapeutics for CNS diseases. Neurotherapeutics 10:473-485.","DOI":"10.1007\/s13311-013-0183-8"},{"key":"key-10.4103\/1673-5374.332129-96","doi-asserted-by":"crossref","unstructured":"Ramos-Cabrer P, Campos F (2013) Liposomes and nanotechnology in drug development: focus on neurological targets. Int J Nanomedicine 8:951-960.","DOI":"10.2147\/IJN.S30721"},{"key":"key-10.4103\/1673-5374.332129-97","doi-asserted-by":"crossref","unstructured":"Ren Y, Hauert S, Lo JH, Bhatia SN (2012) Identification and characterization of receptor-specific peptides for siRNA delivery. ACS Nano 6:8620-8631.","DOI":"10.1021\/nn301975s"},{"key":"key-10.4103\/1673-5374.332129-98","doi-asserted-by":"crossref","unstructured":"Resnier P, Montier T, Mathieu V, Benoit J-P, Passirani C (2013) A review of the current status of siRNA nanomedicines in the treatment of cancer. Biomaterials 34:6429-6443.","DOI":"10.1016\/j.biomaterials.2013.04.060"},{"key":"key-10.4103\/1673-5374.332129-99","doi-asserted-by":"crossref","unstructured":"Rhim T, Lee DY, Lee M (2013) Drug delivery systems for the treatment of ischemic stroke. Pharm Res 30:2429-2444.","DOI":"10.1007\/s11095-012-0959-2"},{"key":"key-10.4103\/1673-5374.332129-100","doi-asserted-by":"crossref","unstructured":"Rogers AK, Phillips CM (2020) RNAi pathways repress reprogramming of C. elegans germ cells during heat stress. Nucleic Acids Res 48:4256-4273.","DOI":"10.1093\/nar\/gkaa174"},{"key":"key-10.4103\/1673-5374.332129-101","doi-asserted-by":"crossref","unstructured":"Rungta RL, Choi HB, Lin PJ, Ko RW, Ashby D, Nair J, Manoharan M, Cullis PR, MacVicar BA (2013) Lipid nanoparticle delivery of siRNA to silence neuronal gene expression in the brain. Mol Ther Nucleic Acids 2:e136.","DOI":"10.1038\/mtna.2013.65"},{"key":"key-10.4103\/1673-5374.332129-102","doi-asserted-by":"crossref","unstructured":"Rungta RL, Choi HB, Tyson JR, Malik A, Dissing-Olesen L, Lin PJ, Cain SM, Cullis PR, Snutch TP, MacVicar BA (2015) The cellular mechanisms of neuronal swelling underlying cytotoxic edema. Cell 161:610-621.","DOI":"10.1016\/j.cell.2015.03.029"},{"key":"key-10.4103\/1673-5374.332129-103","doi-asserted-by":"crossref","unstructured":"Sava V, Fihurka O, Khvorova A, Sanchez-Ramos J (2020) Enriched chitosan nanoparticles loaded with siRNA are effective in lowering Huntington\u2019s disease gene expression following intranasal administration. Nanomedicine 24:102119.","DOI":"10.1016\/j.nano.2019.102119"},{"key":"key-10.4103\/1673-5374.332129-104","doi-asserted-by":"crossref","unstructured":"Schroeder A, Levins CG, Cortez C, Langer R, Anderson DG (2010) Lipid-based nanotherapeutics for siRNA delivery. J Intern Med 267:9-21.","DOI":"10.1111\/j.1365-2796.2009.02189.x"},{"key":"key-10.4103\/1673-5374.332129-105","doi-asserted-by":"crossref","unstructured":"Scott LJ (2020) Givosiran: first approval. Drugs 80:335-339.","DOI":"10.1007\/s40265-020-01269-0"},{"key":"key-10.4103\/1673-5374.332129-106","doi-asserted-by":"crossref","unstructured":"Shakeri S, Ashrafizadeh M, Zarrabi A, Roghanian R, Afshar EG, Pardakhty A, Mohammadinejad R, Kumar A, Thakur VK (2020) Multifunctional polymeric nanoplatforms for brain diseases diagnosis, therapy and theranostics. Biomedicines 8:13.","DOI":"10.3390\/biomedicines8010013"},{"key":"key-10.4103\/1673-5374.332129-107","doi-asserted-by":"crossref","unstructured":"Shao Z, Tu S, Shao A (2019) Pathophysiological mechanisms and potential therapeutic targets in intracerebral hemorrhage. Front Pharmacol 10:1079.","DOI":"10.3389\/fphar.2019.01079"},{"key":"key-10.4103\/1673-5374.332129-108","doi-asserted-by":"crossref","unstructured":"Sharma N, Madan P, Lin S (2016) Effect of process and formulation variables on the preparation of parenteral paclitaxel-loaded biodegradable polymeric nanoparticles: a co-surfactant study. Asian J Pharm Sci 11:404-416.","DOI":"10.1016\/j.ajps.2015.09.004"},{"key":"key-10.4103\/1673-5374.332129-109","doi-asserted-by":"crossref","unstructured":"Siaw-Debrah F, Nyanzu M, Ni H, Lin X, Xu Z, Ruan L, Zhuge Q, Huang L (2017) Preclinical studies and translational applications of intracerebral hemorrhage. Biomed Res Int doi:10.1155\/2017\/5135429.","DOI":"10.1155\/2017\/5135429"},{"key":"key-10.4103\/1673-5374.332129-110","doi-asserted-by":"crossref","unstructured":"Singha K, Namgung R, Kim WJ (2011) Polymers in small-interfering RNA delivery. Nucleic Acid Ther 21:133-147.","DOI":"10.1089\/nat.2011.0293"},{"key":"key-10.4103\/1673-5374.332129-111","doi-asserted-by":"crossref","unstructured":"Smith A, McCulloh RJ (2015) Hemopexin and haptoglobin: allies against heme toxicity from hemoglobin not contenders. Front Physiol 6:187.","DOI":"10.3389\/fphys.2015.00187"},{"key":"key-10.4103\/1673-5374.332129-112","doi-asserted-by":"crossref","unstructured":"Song M-S, Rossi JJ (2017) Molecular mechanisms of Dicer: endonuclease and enzymatic activity. Biochem J 474:1603-1618.","DOI":"10.1042\/BCJ20160759"},{"key":"key-10.4103\/1673-5374.332129-113","doi-asserted-by":"crossref","unstructured":"Souweidane MM, Fraser JF, Arkin LM, Sondhi D, Hackett NR, Kaminsky SM, Heier L, Kosofsky BE, Worgall S, Crystal RG (2010) Gene therapy for late infantile neuronal ceroid lipofuscinosis: neurosurgical considerations. J Neurosurg Pediatr 6:115-122.","DOI":"10.3171\/2010.4.PEDS09507"},{"key":"key-10.4103\/1673-5374.332129-114","doi-asserted-by":"crossref","unstructured":"Stenstr\u00f6m P, Manzanares D, Zhang Y, Ce\u00f1a V, Malkoch M (2018) Evaluation of amino-functional polyester dendrimers based on Bis-MPA as nonviral vectors for siRNA delivery. Molecules 23:2028.","DOI":"10.3390\/molecules23082028"},{"key":"key-10.4103\/1673-5374.332129-115","doi-asserted-by":"crossref","unstructured":"Szwargulski P, Wilmes M, Javidi E, Thieben F, Graeser M, Koch M, Gruettner C, Adam G, Gerloff C, Magnus T (2020) Monitoring intracranial cerebral hemorrhage using multicontrast real-time magnetic particle imaging. ACS Nano 14:13913-13923.","DOI":"10.1021\/acsnano.0c06326"},{"key":"key-10.4103\/1673-5374.332129-116","doi-asserted-by":"crossref","unstructured":"Tai W, Gao X (2017) Functional peptides for siRNA delivery. Adv Drug Deliv Rev 110:157-168.","DOI":"10.1016\/j.addr.2016.08.004"},{"key":"key-10.4103\/1673-5374.332129-117","doi-asserted-by":"crossref","unstructured":"Takahashi T, Nakano Y, Ui-Tei K (2018) Current status for application of RNA interference technology as nucleic acid drug. In: Gene Expression and Regulation in Mammalian Cells: Transcription From General Aspects (Uchiumi F, ed), pp149. London: IntechOpen Limited.","DOI":"10.5772\/intechopen.71965"},{"key":"key-10.4103\/1673-5374.332129-118","doi-asserted-by":"crossref","unstructured":"Takahiko I, Sena I, Tasuku H, Hideko N, Nakamura S, Masamitsu S, Hideaki H (2019) Intracellular Fe2+ accumulation in endothelial cells and pericytes induces blood-brain barrier dysfunction in secondary brain injury after brain hemorrhage. Sci Rep 9:6228.","DOI":"10.1038\/s41598-019-42370-z"},{"key":"key-10.4103\/1673-5374.332129-119","doi-asserted-by":"crossref","unstructured":"Teleanu DM, Negut I, Grumezescu V, Grumezescu AM, Teleanu RI (2019) Nanomaterials for drug delivery to the central nervous system. Nanomaterials 9:371.","DOI":"10.3390\/nano9030371"},{"key":"key-10.4103\/1673-5374.332129-120","doi-asserted-by":"crossref","unstructured":"Torrecilla J, Rodr\u00edguez-Gasc\u00f3n A, Solin\u00eds M\u00c1, del Pozo-Rodr\u00edguez A (2014) Lipid nanoparticles as carriers for RNAi against viral infections: current status and future perspectives. Biomed Res Int 2014:161794.","DOI":"10.1155\/2014\/161794"},{"key":"key-10.4103\/1673-5374.332129-121","doi-asserted-by":"crossref","unstructured":"Tschoe C, Bushnell CD, Duncan PW, Alexander-Miller MA, Wolfe SQ (2020) Neuroinflammation after intracerebral hemorrhage and potential therapeutic targets. J Stroke 22:29-46.","DOI":"10.5853\/jos.2019.02236"},{"key":"key-10.4103\/1673-5374.332129-122","doi-asserted-by":"crossref","unstructured":"van Asch CJ, Luitse MJ, Rinkel GJ, van der Tweel I, Algra A, Klijn CJ (2010) Incidence, case fatality, and functional outcome of intracerebral haemorrhage over time, according to age, sex, and ethnic origin: a systematic review and meta-analysis. Lancet Neurol 9:167-176.","DOI":"10.1016\/S1474-4422(09)70340-0"},{"key":"key-10.4103\/1673-5374.332129-123","unstructured":"Vannucci L, Lai M, Chiuppesi F, Ceccherini-Nelli L, Pistello M (2013) Viral vectors: a look back and ahead on gene transfer technology. New Microbiol 36:1-22."},{"key":"key-10.4103\/1673-5374.332129-124","doi-asserted-by":"crossref","unstructured":"Varghese AM, Ang C, Dimaio CJ, Javle MM, Gutierrez M, Yarom N, Stemmer SM, Golan T, Geva R, Semenisty V (2020) A phase II study of siG12D-LODER in combination with chemotherapy in patients with locally advanced pancreatic cancer (PROTACT). J Clin Oncol 38:15_suppl TPS4672.","DOI":"10.1200\/JCO.2020.38.15_suppl.TPS4672"},{"key":"key-10.4103\/1673-5374.332129-125","doi-asserted-by":"crossref","unstructured":"Verma A, Stellacci F (2010) Effect of surface properties on nanoparticle\u2013cell interactions. Small 6:12-21.","DOI":"10.1002\/smll.200901158"},{"key":"key-10.4103\/1673-5374.332129-126","doi-asserted-by":"crossref","unstructured":"Villar-Alvarez E, Leal BH, Martinez-Gonzalez R, Pardo A, Al-Qadi S, Ju \u00e1rez J, V\u00e1ldez MA, Camb\u00f3n A, Barbosa S, Taboada P (2019) SiRNA silencing by chemically modified biopolymeric nanovectors. ACS Omega 4:3904-3921.","DOI":"10.1021\/acsomega.8b02875"},{"key":"key-10.4103\/1673-5374.332129-127","doi-asserted-by":"crossref","unstructured":"Wang D, Tai PWL, Gao G (2019) Adeno-associated virus vector as a platform for gene therapy delivery. Nat Rev Drug Discov 18:358-378.","DOI":"10.1038\/s41573-019-0012-9"},{"key":"key-10.4103\/1673-5374.332129-128","doi-asserted-by":"crossref","unstructured":"Wang L, Zheng S, Zhang L, Xiao H, Gan H, Chen H, Zhai X, Liang P, Zhao J, Li Y (2020) Histone deacetylation 10 alleviates inflammation after intracerebral hemorrhage via the PTPN22\/NLRP3 pathway in rats. Neuroscience 432:247-259.","DOI":"10.1016\/j.neuroscience.2020.02.027"},{"key":"key-10.4103\/1673-5374.332129-129","doi-asserted-by":"crossref","unstructured":"Wang Y, Li P, Kong L (2013) Chitosan-modified PLGA nanoparticles with versatile surface for improved drug delivery. Aaps Pharmscitech 14:585-592.","DOI":"10.1208\/s12249-013-9943-3"},{"key":"key-10.4103\/1673-5374.332129-130","doi-asserted-by":"crossref","unstructured":"Wang Y, Li SY, Shen S, Wang J (2018) Protecting neurons from cerebral ischemia\/reperfusion injury via nanoparticle-mediated delivery of an siRNA to inhibit microglial neurotoxicity. Biomaterials 161:95-105.","DOI":"10.1016\/j.biomaterials.2018.01.039"},{"key":"key-10.4103\/1673-5374.332129-131","doi-asserted-by":"crossref","unstructured":"White E, Bienemann A, Megraw L, Bunnun C, Gill S (2011) Evaluation and optimization of the administration of a selectively replicating herpes simplex viral vector to the brain by convection-enhanced delivery. Cancer Gene Ther 18:358-369.","DOI":"10.1038\/cgt.2011.2"},{"key":"key-10.4103\/1673-5374.332129-132","doi-asserted-by":"crossref","unstructured":"Wilkinson DA, Pandey AS, Thompson BG, Keep RF, Hua Y, Xi G (2018) Injury mechanisms in acute intracerebral hemorrhage. Neuropharmacology 134:240-248.","DOI":"10.1016\/j.neuropharm.2017.09.033"},{"key":"key-10.4103\/1673-5374.332129-133","doi-asserted-by":"crossref","unstructured":"Wold WS, Toth K (2013) Adenovirus vectors for gene therapy, vaccination and cancer gene therapy. Curr Gene Ther 13:421-433.","DOI":"10.2174\/1566523213666131125095046"},{"key":"key-10.4103\/1673-5374.332129-134","doi-asserted-by":"crossref","unstructured":"Wu X, Fu S, Liu Y, Luo H, Li F, Wang Y, Gao M, Cheng Y, Xie Z (2019) NDP-MSH binding melanocortin-1 receptor ameliorates neuroinflammation and BBB disruption through CREB\/Nr4a1\/NF-\u03baB pathway after intracerebral hemorrhage in mice. J Neuroinflammation 16:192.","DOI":"10.1186\/s12974-019-1591-4"},{"key":"key-10.4103\/1673-5374.332129-135","doi-asserted-by":"crossref","unstructured":"Xia Y, Tian J, Chen X (2016) Effect of surface properties on liposomal siRNA delivery. Biomaterials 79:56-68.","DOI":"10.1016\/j.biomaterials.2015.11.056"},{"key":"key-10.4103\/1673-5374.332129-136","doi-asserted-by":"crossref","unstructured":"Xiang Y, Oo NNL, Lee JP, Li Z, Loh XJ (2017) Recent development of synthetic nonviral systems for sustained gene delivery. Drug Discov Today 22:1318-1335.","DOI":"10.1016\/j.drudis.2017.04.001"},{"key":"key-10.4103\/1673-5374.332129-137","doi-asserted-by":"crossref","unstructured":"Yang G, Hu R, Zhang C, Qian C, Luo QQ, Yung WH, Ke Y, Feng H, Qian ZM (2016) A combination of serum iron, ferritin and transferrin predicts outcome in patients with intracerebral hemorrhage. Sci Rep 6:1-10.","DOI":"10.1038\/srep21970"},{"key":"key-10.4103\/1673-5374.332129-138","doi-asserted-by":"crossref","unstructured":"Yang G, Qian C, Zhang C, Bao Y, Liu MY, Jiang F, Li W, Liu Y, Ke Y, Qian ZM (2021) Hepcidin attenuates the iron-mediated secondary neuronal injury after intracerebral hemorrhage in rats. Transl Res 229:53-68.","DOI":"10.1016\/j.trsl.2020.09.002"},{"key":"key-10.4103\/1673-5374.332129-139","doi-asserted-by":"crossref","unstructured":"Yang GQ, Huang JC, Yuan JJ, Zhang Q, Gong CX, Chen Q, Xie Q, Xie LX, Chen R, Qiu ZM, Zhou K, Xu R, Jiang GH, Xiong XY, Yang QW (2020) Prdx1 reduces intracerebral hemorrhage-induced brain injury via targeting inflammation- and apoptosis-related mRNA stability. Front Neurosci 14:181.","DOI":"10.3389\/fnins.2020.00181"},{"key":"key-10.4103\/1673-5374.332129-140","doi-asserted-by":"crossref","unstructured":"Yonezawa S, Koide H, Asai T (2020) Recent advances in siRNA delivery mediated by lipid-based nanoparticles. Adv Drug Deliv Rev 154-155:64-78.","DOI":"10.1016\/j.addr.2020.07.022"},{"key":"key-10.4103\/1673-5374.332129-141","doi-asserted-by":"crossref","unstructured":"Yu S, Xu X, Feng J, Liu M, Hu K (2019) Chitosan and chitosan coating nanoparticles for the treatment of brain disease. Int J Pharm 560:282-293.","DOI":"10.1016\/j.ijpharm.2019.02.012"},{"key":"key-10.4103\/1673-5374.332129-142","doi-asserted-by":"crossref","unstructured":"Yuan X, Naguib S, Wu Z (2011) Recent advances of siRNA delivery by nanoparticles. Expert Opin Drug Deliv 8:521-536.","DOI":"10.1517\/17425247.2011.559223"},{"key":"key-10.4103\/1673-5374.332129-143","doi-asserted-by":"crossref","unstructured":"Zeng J, Chen Y, Ding R, Feng L, Fu Z, Yang S, Deng X, Xie Z, Zheng S (2017) Isoliquiritigenin alleviates early brain injury after experimental intracerebral hemorrhage via suppressing ROS- and\/or NF-\u03baB-mediated NLRP3 inflammasome activation by promoting Nrf2 antioxidant pathway. J Neuroinflammation 14:119.","DOI":"10.1186\/s12974-017-0895-5"},{"key":"key-10.4103\/1673-5374.332129-144","doi-asserted-by":"crossref","unstructured":"Zhang H, Yang B, Mu X, Ahmed SS, Su Q, He R, Wang H, Mueller C, Sena-Esteves M, Brown R (2011) Several rAAV vectors efficiently cross the blood\u2013brain barrier and transduce neurons and astrocytes in the neonatal mouse central nervous system. Mol Ther 19:1440-1448.","DOI":"10.1038\/mt.2011.98"},{"key":"key-10.4103\/1673-5374.332129-145","doi-asserted-by":"crossref","unstructured":"Zhang N, He L, Wu W (2021) Self-assembling peptide nanofibrous scaffolds in central nervous system lesions. In: Nanomedicines for brain drug delivery (Morales J, Gaillard P, ed), pp103-117. Berlin: Springer.","DOI":"10.1007\/978-1-0716-0838-8_4"},{"key":"key-10.4103\/1673-5374.332129-146","doi-asserted-by":"crossref","unstructured":"Zhang X, Yang X, Ji J, Liu A, Zhai G (2016) Tumor targeting strategies for chitosan-based nanoparticles. Colloids Surf B Biointerfaces 148:460-473.","DOI":"10.1016\/j.colsurfb.2016.09.020"},{"key":"key-10.4103\/1673-5374.332129-147","doi-asserted-by":"crossref","unstructured":"Zhang Y, Friedlander R (2011) Using non-coding small RNAs to develop therapies for Huntington\u2019s disease. Gene Ther 18:1139-1149.","DOI":"10.1038\/gt.2011.170"},{"key":"key-10.4103\/1673-5374.332129-148","doi-asserted-by":"crossref","unstructured":"Zhang Y, Han B, He Y, Li D, Ma X, Liu Q, Hao J (2017) MicroRNA-132 attenuates neurobehavioral and neuropathological changes associated with intracerebral hemorrhage in mice. Neurochem Int 107:182-190.","DOI":"10.1016\/j.neuint.2016.11.011"},{"key":"key-10.4103\/1673-5374.332129-149","doi-asserted-by":"crossref","unstructured":"Zhao K, Zhang Y, Zhang X, Shi C, Wang X, Wang X, Jin Z, Cui S (2014) Chitosan-coated poly (lactic-co-glycolic) acid nanoparticles as an efficient delivery system for Newcastle disease virus DNA vaccine. Int J Nanomedicine 9:4609-4619.","DOI":"10.2147\/IJN.S70633"},{"key":"key-10.4103\/1673-5374.332129-150","doi-asserted-by":"crossref","unstructured":"Zhao W, Wu C, Stone C, Ding Y, Ji X (2020) Treatment of intracerebral hemorrhage: Current approaches and future directions. J Neurol Sci 416:117020.","DOI":"10.1016\/j.jns.2020.117020"},{"key":"key-10.4103\/1673-5374.332129-151","doi-asserted-by":"crossref","unstructured":"Zheng M, Tao W, Zou Y, Farokhzad OC, Shi B (2018) Nanotechnology-based strategies for siRNA brain delivery for disease therapy. Trends Biotechnol 36:562-575.","DOI":"10.1016\/j.tibtech.2018.01.006"},{"key":"key-10.4103\/1673-5374.332129-152","doi-asserted-by":"crossref","unstructured":"Zhou Y, Peng Z, Seven ES, Leblanc RM (2018) Crossing the blood-brain barrier with nanoparticles. J Control Release 270:290-303.","DOI":"10.1016\/j.jconrel.2017.12.015"},{"key":"key-10.4103\/1673-5374.332129-153","doi-asserted-by":"crossref","unstructured":"Zhu Q, Enkhjargal B, Huang L, Zhang T, Sun C, Xie Z, Wu P, Mo J, Tang J, Xie Z, Zhang JH (2018) Aggf1 attenuates neuroinflammation and BBB disruption via PI3K\/Akt\/NF-\u03baB pathway after subarachnoid hemorrhage in rats. J Neuroinflammation 15:178.","DOI":"10.1186\/s12974-018-1211-8"},{"key":"key-10.4103\/1673-5374.332129-154","doi-asserted-by":"crossref","unstructured":"Zhu Y, Liu C, Pang Z (2019) Dendrimer-based drug delivery systems for brain targeting. Biomolecules 9:790.","DOI":"10.3390\/biom9120790"},{"key":"key-10.4103\/1673-5374.332129-155","doi-asserted-by":"crossref","unstructured":"Zinn E, Vandenberghe LH (2014) Adeno-associated virus: fit to serve. Curr Opin Virol 8:90-97.","DOI":"10.1016\/j.coviro.2014.07.008"}],"container-title":["Neural Regeneration Research"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:23:51Z","timestamp":1787163831000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/1673-5374.332129"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"references-count":155,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022]]}},"alternative-id":["332129"],"URL":"https:\/\/doi.org\/10.4103\/1673-5374.332129","relation":{},"ISSN":["1673-5374"],"issn-type":[{"value":"1673-5374","type":"print"}],"subject":[],"published":{"date-parts":[[2022]]}}}